This is a welcome text with instructions

Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date
on information about hepatitis and to answer some of our web site and training audience questions.
People are encouraged to submit questions and post comments.

Be sure to check out our other blog: Hepatitis & Tattoos

Alan Franciscus
Editor-inChief
HCV Advocate
HBV Advocate


Tuesday, October 11, 2011

Inovio, VGX to develop vaccines for Hepatitis B and Hepatitis C

Synthetic multi-antigen hepatitis C virus (HCV) vaccine targeting the antigens NS3/4A will be the first product to enter clinical testing, which will be delivered with Inovio's Cellectra delivery device

The positive preclinical results from Inovio's novel SynCon vaccine targeting NS3/4A support the development of the vaccines.

Read more...
Posted by HCV Advocate at 11:27 AM
Labels: , ,

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)